Icahn Carl’s Herbalife HLF Stock Holding History

Icahn Carl’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,018,886	Closed	-$356M	–	18
2021 Q1	$356M	Sell	8,018,886 -12,486,993	-61%	-$616M	1.49%	12
2020 Q4	$985M	Hold	20,505,879	–	–	4.91%	4
2020 Q3	$957M	Sell	20,505,879 -14,722,025	-42%	-$723M	5.51%	2
2020 Q2	$1.58B	Hold	35,227,904	–	–	8.03%	3
2020 Q1	$1.03B	Hold	35,227,904	–	–	5.71%	4
2019 Q4	$1.68B	Hold	35,227,904	–	–	6.42%	3
2019 Q3	$1.33B	Hold	35,227,904	–	–	5.19%	3
2019 Q2	$1.51B	Hold	35,227,904	–	–	5.68%	4
2019 Q1	$1.87B	Hold	35,227,904	–	–	7.74%	3
2018 Q4	$2.08B	Hold	35,227,904	–	–	10.17%	3
2018 Q3	$1.92B	Hold	35,227,904	–	–	7.62%	3
2018 Q2	$1.89B	Sell	35,227,904 -10,516,744	-23%	-$553M	7.84%	3
2018 Q1	$2.23B	Hold	45,744,648	–	–	11.08%	2
2017 Q4	$1.55B	Hold	45,744,648	–	–	6.84%	5
2017 Q3	$1.55B	Hold	45,744,648	–	–	7.3%	4
2017 Q2	$1.63B	Hold	45,744,648	–	–	8.34%	3
2017 Q1	$1.33B	Buy	45,744,648 +744,648	+2%	+$20.7M	6.67%	6
2016 Q4	$1.08B	Buy	45,000,000 +5,776,942	+15%	+$158M	4.84%	8
2016 Q3	$1.22B	Buy	39,223,058 +5,223,058	+15%	+$165M	6.14%	6
2016 Q2	$995M	Hold	34,000,000	–	–	4.91%	8
2016 Q1	$1.05B	Hold	34,000,000	–	–	4.87%	8
2015 Q4	$912M	Hold	34,000,000	–	–	3.1%	11
2015 Q3	$927M	Hold	34,000,000	–	–	3.32%	10
2015 Q2	$937M	Hold	34,000,000	–	–	3%	9
2015 Q1	$727M	Hold	34,000,000	–	–	2.27%	10
2014 Q4	$641M	Hold	34,000,000	–	–	2.01%	10
2014 Q3	$744M	Hold	34,000,000	–	–	2.21%	11
2014 Q2	$1.1B	Hold	34,000,000	–	–	2.85%	9
2014 Q1	$974M	Buy	34,000,000 +67,030	+0.2%	+$2.21M	2.96%	9
2013 Q4	$1.34B	Hold	33,932,970	–	–	4.38%	7
2013 Q3	$1.18B	Hold	33,932,970	–	–	4.81%	8
2013 Q2	$766M	Buy	+33,932,970	New	+$722M	3.56%	9

Other funds holding HLF

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DVI

Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Icahn Carl's HLF Position: Q2 2021 in Review

Icahn Carl sold out of Herbalife (HLF) in Q2 2021, closing a stake of 8,018,886 shares — an estimated $356M sold.

Icahn Carl first reported a position in HLF in Q2 2013 and held it in 32 quarters. The position peaked at $2.23B in Q1 2018. 248 funds tracked by Wall St. Rank hold HLF as of Q2 2021.

Icahn Carl reported no remaining Herbalife position as of Q2 2021 after selling out during the quarter.
Icahn Carl sold 8,018,886 Herbalife shares in Q2 2021, an estimated $356M.
Icahn Carl first reported a position in Herbalife in Q2 2013 and held it in 32 quarters.
Icahn Carl's Herbalife position peaked at $2.23B in Q1 2018.
248 funds tracked by Wall St. Rank held Herbalife as of Q2 2021.

Based on Icahn Carl's 13F filing for Q2 2021, filed 13 Aug 2021.